ArticleAntimicrobial agents and chemotherapy2015

IMP-51, a novel IMP-type metallo-β-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.

Tatsuya Tada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.